Ferredoxin-NADP Reductase
"Ferredoxin-NADP Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.
| Descriptor ID |
D005287
|
| MeSH Number(s) |
D08.811.682.667.076
|
| Concept/Terms |
Ferredoxin-NADP Reductase- Ferredoxin-NADP Reductase
- Ferredoxin NADP Reductase
- Reductase, Ferredoxin-NADP
- NADPH-Ferredoxin Reductase
- NADPH Ferredoxin Reductase
- Reductase, NADPH-Ferredoxin
- Adrenodoxin Reductase
- Reductase, Adrenodoxin
- Iron-Sulfur Protein Reductase
- Iron Sulfur Protein Reductase
- Protein Reductase, Iron-Sulfur
- Reductase, Iron-Sulfur Protein
|
Below are MeSH descriptors whose meaning is more general than "Ferredoxin-NADP Reductase".
Below are MeSH descriptors whose meaning is more specific than "Ferredoxin-NADP Reductase".
This graph shows the total number of publications written about "Ferredoxin-NADP Reductase" by people in this website by year, and whether "Ferredoxin-NADP Reductase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ferredoxin-NADP Reductase" by people in Profiles.
-
Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One. 2013; 8(1):e53475.
-
Variants in folate pathway genes as modulators of genetic instability and lung cancer risk. Genes Chromosomes Cancer. 2011 Jan; 50(1):1-12.
-
Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int. 2005 Dec; 68(6):2857-62.
-
Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):547-55.
-
Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1188-93.
-
Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis. 2004 May; 174(1):43-8.
-
Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab. 2003 Mar; 78(3):216-21.
-
Maternal folate polymorphisms and the etiology of human nondisjunction. Am J Hum Genet. 2001 Aug; 69(2):434-9.
-
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):3059-64.